These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29574992)

  • 1. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
    Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
    J Cell Physiol; 2018 Sep; 233(9):7305-7319. PubMed ID: 29574992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
    Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I; Tozlu S; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
    J Oncol Pharm Pract; 2022 Mar; 28(2):310-325. PubMed ID: 33509057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
    Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
    Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.
    Martens JW; Nimmrich I; Koenig T; Look MP; Harbeck N; Model F; Kluth A; Bolt-de Vries J; Sieuwerts AM; Portengen H; Meijer-Van Gelder ME; Piepenbrock C; Olek A; Höfler H; Kiechle M; Klijn JG; Schmitt M; Maier S; Foekens JA
    Cancer Res; 2005 May; 65(10):4101-17. PubMed ID: 15899800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation, mRNA expression of goat tumor‑associated genes and mRNA expression of DNA methyltransferase in enzootic nasal tumors.
    Quan Z; Ye N; Hao Z; Wen C; Liao H; Zhang M; Luo L; Cao S; Wen X; Wu R; Yan Q
    Mol Med Rep; 2015 Oct; 12(4):6275-85. PubMed ID: 26252527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
    Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
    Liu J; Prager-van der Smissen WJ; Look MP; Sieuwerts AM; Smid M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    Cancer Lett; 2016 Jun; 376(1):104-9. PubMed ID: 27018307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
    Brennan DJ; Laursen H; O'Connor DP; Borgquist S; Uhlen M; Gallagher WM; Pontén F; Millikan RC; Rydén L; Jirström K
    Breast Cancer Res; 2011 Jan; 13(1):R12. PubMed ID: 21281480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
    Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
    PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease.
    Ben Gacem R; Ben Abdelkrim O; Ziadi S; Ben Dhiab M; Trimeche M
    Tumour Biol; 2014 May; 35(5):4047-56. PubMed ID: 24375250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
    Bièche I; Girault I; Urbain E; Tozlu S; Lidereau R
    Breast Cancer Res; 2004; 6(3):R252-63. PubMed ID: 15084249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.
    Stone A; Valdés-Mora F; Gee JM; Farrow L; McClelland RA; Fiegl H; Dutkowski C; McCloy RA; Sutherland RL; Musgrove EA; Nicholson RI
    PLoS One; 2012; 7(7):e40466. PubMed ID: 22808167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
    Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties.
    Lin X; Li J; Yin G; Zhao Q; Elias D; Lykkesfeldt AE; Stenvang J; Brünner N; Wang J; Yang H; Bolund L; Ditzel HJ
    Breast Cancer Res; 2013 Dec; 15(6):R119. PubMed ID: 24355041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
    Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.